[The analysis to data from Chinese Rheumatism Data Center external quality assurance program for autoantibodies in 2021].

Bai, Y N; Deng, C W; Song, N; Qin, J L; Li, M T; Zeng, X F; Hu, C J

Bai, Y N; Deng, C W; Song, N; Qin, J L; Li, M T; Zeng, X F; Hu, C J.

Afiliação

Bai YN; Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Pek
Deng CW; Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Pek
Song N; Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Pek
Qin JL; Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Pek
Li MT; Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Pek
Zeng XF; Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Pek
Hu CJ; Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Pek

Zhonghua Yu Fang Yi Xue Za Zhi ; 56(12): 1860-1867, 2022 Dec 06.

Article em Zh | MEDLINE | ID: mdl-36536579

Assuntos

Autoanticorpos; Doenças Reumáticas; Humanos; Anticorpos Anticardiolipina/análise; beta 2-Glicoproteína I; Estudos Retrospectivos; China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Autoanticorpos / Doenças Reumáticas Tipo de estudo: Observational_studies / Qualitative_research Limite: Humans País/Região como assunto: Asia Idioma: Zh Revista: Zhonghua Yu Fang Yi Xue Za Zhi Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google